Texting your way to better health: study tests SMS diet coach for cancer survivors
NCT ID NCT05746195
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested whether sending personalized text messages could help colorectal cancer survivors eat more whole grains and less refined grains. Forty-six survivors who had finished active treatment received text messages and nutrition materials. The main goal was to see if people would use the system and find it helpful, not to measure long-term health changes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- text message dietary intervention
- What this could lead to
- If it works, this could offer a simple, low-cost way to help colorectal cancer survivors improve their diet and potentially lower their risk of death from the disease.
- What could go wrong
- This is a very small, early feasibility study with only 46 participants. It only tested whether people would use the system, not whether it actually improves health outcomes. Results may not apply to everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
46 people
The number who actually took part.
- Started
-
Nov 2023
- Finished
-
Nov 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age \> 18 years. 2. Subject has provided informed consent. 3. Diagnosis of colon or rectal adenocarcinoma. 4. Not on active treatment at the time of screening and not expected to receive active anticancer therapy (e.g., surgery, radiation, chemotherapy) during the study period. 5. At least 6 weeks since a major surgery and fully recovered. 6. Owns a mobile phone and is willing and able to receive and send text messages. 7. Able to speak/read English or Spanish. 8. Based on a screening survey, eat grains and =\<50% of total grains are whole grains. Exclusion Criteria: 1\. Does not meet any of the above inclusion criteria.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colon adenocarcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
Zuckerberg San Francisco General
San Francisco, California, 94110, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immunotherapy added to standard treatment aims to save the anus in Ultra-Low rectal cancer
- Can surgeons spare nerves and still cure colon cancer?
- New injectable drug tested against Hard-to-Treat solid tumors
- Could a nasal tube replace a temporary ileostomy after rectal cancer surgery?
- Blood test aims to catch Cancer's return earlier
- Blood test guides immunotherapy for hidden cancer cells